EUVIMEDEUVIMED entdecken
Crossref

Folic acid-modified biocompatible Pullulan/poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells

Mohammadreza Ghaffarlou, S Duygu Sütekin, Elif Karacaoğlu, Seçil Karahisar Turan, Özlem Gülüm İnci, Olgun Güven, Murat Barsbay

European Journal of Pharmaceutics and Biopharmaceutics · 2023

DOI: 10.1016/j.ejpb.2023.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023. Verfasst von Mohammadreza Ghaffarlou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hacettepe University, Department of Chemistry, Beytepe, 06800 Ankara, Turkey. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Ankara Universitesi, International Atomic Energy Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We prepared a novel nanogel consisting of poly(acrylic acid) (PAA) and pullulan (Pull) via a facile and green irradiation protocol. Synthesized nanogels were modified with bovine serum albumin (BSA) and folic acid (FA) and then loaded with doxorubicin (DOX) to obtain a delivery system with tumor-specific targeting ability and enhanced biocompatibility. In-vitro DOX release was investigated at different pH values, and it was found that DOX release was higher in acidic media, which is an advantage for the internalization of nanoparticles in acidic tumor environment. MTT assay and DAPI staining were performed to evaluate the effects of nanogels on L929 and MCF-7 cells. Based on the results of in vitro studies, DOX-loaded nanogels were found to be effective on cancer cells, while the neat ones were nondestructive in both lines. Overall, we envision that the biocompatible and tumor-specific nanogels could be a promising safe drug carrier system for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsHumansNanogelsMCF-7 CellsFolic AcidDoxorubicinDrug CarriersHydrogen-Ion ConcentrationDrug Delivery SystemsAcrylic ResinsGlucans

Stichwörter der Autor:innen

Cancer therapyFolic acidMCF-7NanogelPullulanpH-sensitive

Substanzen

NanogelsFolic AcidDoxorubicinDrug Carrierscarbopol 940Acrylic ResinspullulanGlucans

Autor:innen und Institutionen

  • Hacettepe University, Department of Chemistry, Beytepe, 06800 Ankara, Turkey.
  • Hacettepe University, Department of Biology, Beytepe, 06800 Ankara, Turkey.
  • Hacettepe University, Department of Chemistry, Beytepe, 06800 Ankara, Turkey. Electronic address: mbarsbay@hacettepe.edu.tr.

Förderung

  • Ankara Universitesi
  • International Atomic Energy Agency

Zitieren

APA

Ghaffarlou, M., Sütekin, S. D., Karacaoğlu, E., Karahisar Turan, S., İnci, Ö. G., Güven, O., & Barsbay, M. (2023). Folic acid-modified biocompatible Pullulan/poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2023.02.001

Vancouver

Ghaffarlou M, Sütekin SD, Karacaoğlu E, Karahisar Turan S, İnci ÖG, Güven O, et al. Folic acid-modified biocompatible Pullulan/poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. 2023. doi:10.1016/j.ejpb.2023.02.001

BibTeX
@article{Ghaffarlou2023,
  author = {Ghaffarlou, Mohammadreza and Sütekin, S Duygu and Karacaoğlu, Elif and Karahisar Turan, Seçil and İnci, Özlem Gülüm and Güven, Olgun and Barsbay, Murat},
  title = {Folic acid-modified biocompatible Pullulan/poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  doi = {10.1016/j.ejpb.2023.02.001}
}
Kostenlos starten →